06/24/2021 | Press release | Distributed by Public on 06/24/2021 15:18
|
• |
Revenues were approximately €7.2 million for the three months ended March 31, 2021, compared to approximately €1.9 million for the three months ended March 31, 2020. This increase is mainly attributable to the achievement of PAC (Preliminary Acceptance Certificate) of the Talasol photovoltaic facility (the 'Talasol PV Plant') on January 27, 2021, upon which the Company commenced recognition of revenues. The increase also resulted from the acquisition of the Groen Gas Gelderland B.V. biogas facility (the 'Gelderland Biogas Plant') in December 2020 and improved operational efficiency at the Company's biogas plants in the Netherlands.
|
|
• |
Operating expenses were approximately €3.2 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. Depreciation expenses were approximately €3.1 million for the three months ended March 31, 2021, compared to approximately €0.7 million for the three months ended March 31, 2020. The increase in operating expenses and in depreciation expenses is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
|
|
• |
Project development costs were approximately €0.5 million for the three months ended March 31, 2021, compared to approximately €1.8 million for the three months ended March 31, 2020. The decrease in project development costs is mainly due to capitalization of expenses in connection with the pumped-hydro storage project in the Manara Cliff commencing the fourth quarter of 2020.
|
|
• |
General and administrative expenses were approximately €1.3 million for the three months ended March 31, 2021, compared to approximately €1.1 million for the three months ended March 31, 2020. There was no material change in the composition of the expenses included in general and administrative expenses between the two periods.
|
|
• |
Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €0.6 million for the three months ended March 31, 2021, compared to approximately €1.3 million for the three months ended March 31, 2020. The decrease in the Company's share of profit of equity accounted investee is mainly attributable to the decrease in Dorad Energy Ltd.'s revenues.
|
|
• |
Financing expenses, net were approximately €2.8 million for the three months ended March 31, 2021, compared to approximately €0.4 million for the three months ended March 31, 2020. The increase in financing expenses, net, was mainly attributable to €0.8 million of expenses due to the early repayment of the Company's Series B Debentures and financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC.
|
|
• |
Tax benefits were approximately €0.3 million for the three months ended March 31, 2021, compared to taxes on income of approximately €0.1 million for the three months ended March 31, 2020.
|
|
• |
Loss for the three months ended March 31, 2021 was approximately €2.7 million, compared to a loss of approximately €1.9 million for the three months ended March 31, 2020.
|
|
• |
Total other comprehensive loss was approximately €2.4 million for the three months ended March 31, 2021, compared to other comprehensive income of approximately €14 million for the three months ended March 31, 2020. The decrease in total other comprehensive income mainly resulted from changes in fair value of cash flow hedges.
|
|
• |
Total comprehensive loss was approximately €5 million for the three months ended March 31, 2021, compared to total comprehensive income of approximately €12.1 million for the three months ended March 31, 2020.
|
|
• |
EBITDA was approximately €2.9 million for the three months ended March 31, 2021, compared to EBITDA loss of approximately €(0.6) million for the three months ended March 31, 2020. See the table on page 12 of this press release for a reconciliation of these numbers to profit and loss.
|
|
• |
Net cash provided by operating activities was approximately €1.3 million for the three months ended March 31, 2021, compared to net cash used in operating activities of approximately €0.5 million for the three months ended March 31, 2020. The increase is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the Gelderland Biogas Plant acquisition in December 2020.
|
|
• |
As of June 1, 2021, the Company held approximately €78 million in cash and cash equivalents and approximately €9.8 million in restricted short-term and long-term cash.
|
|
• |
Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
|
|
• |
9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
|
|
• |
51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
|
|
• |
Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
|
|
• |
83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
|
March 31
|
December 31,
|
March 31,
|
||||||||||
2021
|
2020
|
2021
|
||||||||||
Unaudited
|
Audited
|
Unaudited
|
||||||||||
€ in thousands
|
Convenience Translation into US$ in thousands**
|
|||||||||||
Assets
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
105,020
|
66,845
|
123,249
|
|||||||||
Marketable securities
|
-
|
1,761
|
-
|
|||||||||
Short term deposits
|
-
|
8,113
|
-
|
|||||||||
Restricted cash
|
2,500
|
-
|
2,934
|
|||||||||
Receivable from concession project
|
1,533
|
1,491
|
1,799
|
|||||||||
Trade and other receivables
|
9,071
|
9,825
|
10,646
|
|||||||||
118,124
|
88,035
|
138,628
|
||||||||||
Non-current assets
|
||||||||||||
Investment in equity accounted investee
|
33,229
|
32,234
|
38,997
|
|||||||||
Advances on account of investments
|
2,430
|
2,423
|
2,852
|
|||||||||
Receivable from concession project
|
25,009
|
25,036
|
29,350
|
|||||||||
Fixed assets
|
278,363
|
264,095
|
326,680
|
|||||||||
Right-of-use asset
|
12,473
|
17,209
|
14,638
|
|||||||||
Intangible asset
|
4,552
|
4,604
|
5,342
|
|||||||||
Restricted cash and deposits
|
7,025
|
9,931
|
8,244
|
|||||||||
Deferred tax
|
4,896
|
3,605
|
5,746
|
|||||||||
Long term receivables
|
66
|
2,762
|
77
|
|||||||||
Derivatives
|
5,480
|
10,238
|
6,431
|
|||||||||
373,523
|
372,137
|
438,357
|
||||||||||
Total assets
|
491,647
|
460,172
|
576,985
|
|||||||||
Liabilities and Equity
|
||||||||||||
Current liabilities
|
||||||||||||
Current maturities of long term bank loans
|
13,331
|
10,232
|
15,645
|
|||||||||
Current maturities of long term loans
|
3,549
|
4,021
|
4,165
|
|||||||||
Debentures
|
8,295
|
10,600
|
9,735
|
|||||||||
Trade payables
|
2,380
|
12,387
|
2,793
|
|||||||||
Other payables
|
10,232
|
7,912
|
12,008
|
|||||||||
37,787
|
45,152
|
44,346
|
||||||||||
Non-current liabilities
|
||||||||||||
Lease liability
|
12,455
|
17,299
|
14,617
|
|||||||||
Long-term loans
|
151,988
|
134,520
|
178,369
|
|||||||||
Other long-term bank loans
|
54,015
|
49,396
|
63,391
|
|||||||||
Debentures
|
92,941
|
72,124
|
109,073
|
|||||||||
Deferred tax
|
7,982
|
7,806
|
9,367
|
|||||||||
Other long-term liabilities
|
4,351
|
513
|
5,106
|
|||||||||
Derivatives
|
6,308
|
8,336
|
7,403
|
|||||||||
330,040
|
289,994
|
387,326
|
||||||||||
Total liabilities
|
367,827
|
335,146
|
431,672
|
|||||||||
Equity
|
||||||||||||
Share capital
|
25,578
|
25,102
|
30,018
|
|||||||||
Share premium
|
85,756
|
82,401
|
100,641
|
|||||||||
Treasury shares
|
(1,736
|
)
|
(1,736
|
)
|
(2,037
|
)
|
||||||
Transaction reserve with non-controlling Interests
|
5,145
|
6,106
|
6,038
|
|||||||||
Reserves
|
3,052
|
4,164
|
3,582
|
|||||||||
Retained earnings
|
6,122
|
8,191
|
7,185
|
|||||||||
Total equity attributed to shareholders of the Company
|
123,917
|
124,228
|
145,427
|
|||||||||
Non-Controlling Interest
|
(97
|
)
|
798
|
(114
|
)
|
|||||||
Total equity
|
123,820
|
125,026
|
145,313
|
|||||||||
Total liabilities and equity
|
491,647
|
460,172
|
576,985
|
For the three months ended March 31,
|
For the year ended December 31,
|
For the three months ended March 31,
|
||||||||||||||
2021
|
2020
|
2020
|
2021
|
|||||||||||||
Unaudited
|
Audited
|
Unaudited
|
||||||||||||||
€ in thousands*
|
€ in thousands*
|
Convenience Translation into US$** in thousands*
|
||||||||||||||
Revenues
|
7,200
|
1,943
|
9,645
|
8,450
|
||||||||||||
Operating expenses
|
(3,217
|
)
|
(1,061
|
)
|
(4,951
|
)
|
(3,775
|
)
|
||||||||
Depreciation and amortization
|
(3,051
|
)
|
(726
|
)
|
(2,975
|
)
|
(3,581
|
)
|
||||||||
Gross profit
|
932
|
156
|
1,719
|
1,094
|
||||||||||||
Project development costs
|
(505
|
)
|
(1,754
|
)
|
(3,491
|
)
|
(593
|
)
|
||||||||
General and administrative expenses
|
(1,263
|
)
|
(1,081
|
)
|
(4,512
|
)
|
(1,482
|
)
|
||||||||
Share of profits of equity accounted investee
|
617
|
1,331
|
1,525
|
724
|
||||||||||||
Other expenses, net
|
-
|
-
|
2,100
|
-
|
||||||||||||
Operating loss
|
(219
|
)
|
(1,348
|
)
|
(2,659
|
)
|
(257
|
)
|
||||||||
Financing income
|
912
|
425
|
2,134
|
1,070
|
||||||||||||
Financing income in connection with derivatives, net
|
(124
|
)
|
954
|
1,094
|
(146
|
)
|
||||||||||
Financing expenses
|
(3,554
|
)
|
(1,792
|
)
|
(6,862
|
)
|
(4,171
|
)
|
||||||||
Financing expenses, net
|
(2,766
|
)
|
(413
|
)
|
(3,634
|
)
|
(3,247
|
)
|
||||||||
Loss before taxes on income
|
(2,985
|
)
|
(1,761
|
)
|
(6,293
|
)
|
(3,504
|
)
|
||||||||
Tax benefit (Taxes on income)
|
319
|
(104
|
)
|
125
|
374
|
|||||||||||
Loss for the period
|
(2,666
|
)
|
(1,865
|
)
|
(6,168
|
)
|
(3,130
|
)
|
||||||||
Loss attributable to:
|
||||||||||||||||
Owners of the Company
|
(2,069
|
)
|
(1,417
|
)
|
(4,627
|
)
|
(2,428
|
)
|
||||||||
Non-controlling interests
|
(597
|
)
|
(448
|
)
|
(1,541
|
)
|
(702
|
)
|
||||||||
Loss for the period
|
(2,666
|
)
|
(1,865
|
)
|
(6,168
|
)
|
(3,130
|
)
|
||||||||
Other comprehensive income (loss) items that after
|
||||||||||||||||
initial recognition in comprehensive income (loss)
|
||||||||||||||||
were or will be transferred to profit or loss:
|
||||||||||||||||
Foreign currency translation differences for foreign operations
|
562
|
(199
|
)
|
(482
|
)
|
660
|
||||||||||
Effective portion of change in fair value of cash flow hedges
|
(1,929
|
)
|
14,112
|
2,210
|
(2,264
|
)
|
||||||||||
Net change in fair value of cash flow hedges transferred to profit or loss
|
(1,004
|
)
|
103
|
555
|
(1,178
|
)
|
||||||||||
Total other comprehensive income (loss)
|
(2,371
|
)
|
14,016
|
2,283
|
(2,782
|
)
|
||||||||||
Total other comprehensive income (loss) attributable to:
|
||||||||||||||||
Owners of the Company
|
(1,112
|
)
|
6,901
|
881
|
(1,305
|
)
|
||||||||||
Non-controlling interests
|
(1,259
|
)
|
7,115
|
1,402
|
(1,477
|
)
|
||||||||||
Total other comprehensive income (loss) for the period
|
(2,371
|
)
|
14,016
|
2,283
|
(2,782
|
)
|
||||||||||
Total comprehensiveincome (loss) for the period
|
(5,037
|
)
|
12,151
|
(3,885
|
)
|
(5,912
|
)
|
|||||||||
Total comprehensive income (loss) attributable to:
|
||||||||||||||||
Owners of the Company
|
(3,181
|
)
|
5,484
|
(3,746
|
)
|
(3,733
|
)
|
|||||||||
Non-controlling interests
|
(1,856
|
)
|
6,667
|
(139
|
)
|
(2,179
|
)
|
|||||||||
Total comprehensiveincome (loss) for the period
|
(5,037
|
)
|
12,151
|
(3,885
|
)
|
(5,912
|
)
|
|||||||||
Basic net loss per share
|
(0.16
|
)
|
(0.12
|
)
|
(0.38
|
)
|
(0.19
|
)
|
||||||||
Diluted net loss per share
|
(0.16
|
)
|
(0.12
|
)
|
(0.38
|
)
|
(0.19
|
)
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Retained earnings
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the three month ended March 31, 2021 (unaudited):
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2021
|
25,102
|
82,401
|
8,191
|
(1,736
|
)
|
3,823
|
341
|
6,106
|
124,228
|
798
|
125,026
|
|||||||||||||||||||||||||||||
Loss for the period
|
-
|
-
|
(2,069
|
)
|
-
|
-
|
-
|
-
|
(2,069
|
)
|
(597
|
)
|
(2,666
|
)
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
-
|
-
|
-
|
-
|
558
|
(1,670
|
)
|
-
|
(1,112
|
)
|
(1,259
|
)
|
(2,371
|
)
|
||||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
-
|
-
|
(2,069
|
)
|
-
|
558
|
(1,670
|
)
|
-
|
(3,181
|
)
|
(1,856
|
)
|
(5,037
|
)
|
|||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Buy of shares in subsidiaries from non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(961
|
)
|
(961
|
)
|
961
|
-
|
||||||||||||||||||||||||||||
Warrants exercise
|
454
|
3,348
|
-
|
-
|
-
|
-
|
-
|
3,802
|
-
|
3,802
|
||||||||||||||||||||||||||||||
Options exercise
|
22
|
-
|
-
|
-
|
-
|
-
|
-
|
22
|
-
|
22
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
7
|
-
|
-
|
-
|
-
|
-
|
7
|
-
|
7
|
||||||||||||||||||||||||||||||
Balance as at
|
||||||||||||||||||||||||||||||||||||||||
March 31, 2021
|
25,578
|
85,756
|
6,122
|
(1,736
|
)
|
4,381
|
(1,329
|
)
|
5,145
|
123,917
|
(97
|
)
|
123,820
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Retained earnings
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the three month ended March 31, 2020 (unaudited):
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2020
|
21,998
|
64,160
|
12,818
|
(1,736
|
)
|
4,356
|
(1,073
|
)
|
6,106
|
106,629
|
937
|
107,566
|
||||||||||||||||||||||||||||
Loss for the period
|
-
|
-
|
(1,417
|
)
|
-
|
-
|
-
|
-
|
(1,417
|
)
|
(448
|
)
|
(1,865
|
)
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
-
|
-
|
-
|
-
|
(223
|
)
|
7,124
|
-
|
6,901
|
7,115
|
14,016
|
|||||||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
-
|
-
|
(1,417
|
)
|
-
|
(223
|
)
|
7,124
|
-
|
5,484
|
6,667
|
12,151
|
||||||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of ordinary shares
|
1,935
|
11,253
|
-
|
-
|
-
|
-
|
-
|
13,188
|
-
|
13,188
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
14
|
-
|
-
|
-
|
-
|
-
|
14
|
-
|
14
|
||||||||||||||||||||||||||||||
Balance as at
|
||||||||||||||||||||||||||||||||||||||||
March 31, 2020
|
23,933
|
75,427
|
11,401
|
(1,736
|
)
|
4,133
|
6,051
|
6,106
|
125,315
|
7,604
|
132,919
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Retained earnings
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
For the year ended
|
||||||||||||||||||||||||||||||||||||||||
December 31, 2020 (Audited):
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2020
|
21,998
|
64,160
|
12,818
|
(1,736
|
)
|
4,356
|
(1,073
|
)
|
6,106
|
106,629
|
937
|
107,566
|
||||||||||||||||||||||||||||
Loss for the year
|
-
|
-
|
(4,627
|
)
|
-
|
-
|
-
|
-
|
(4,627
|
)
|
(1,541
|
)
|
(6,168
|
)
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the year
|
-
|
-
|
-
|
-
|
(533
|
)
|
1,414
|
-
|
881
|
1,402
|
2,283
|
|||||||||||||||||||||||||||||
Total comprehensive income (loss) for the year
|
-
|
-
|
(4,627
|
)
|
-
|
(533
|
)
|
1,414
|
-
|
(3,746
|
)
|
(139
|
)
|
(3,885
|
)
|
|||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Issuance of ordinary shares
|
3,084
|
18,191
|
-
|
-
|
-
|
-
|
-
|
21,275
|
-
|
21,275
|
||||||||||||||||||||||||||||||
Options exercise
|
20
|
-
|
-
|
-
|
-
|
-
|
-
|
20
|
-
|
20
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
50
|
-
|
-
|
-
|
-
|
-
|
50
|
-
|
50
|
||||||||||||||||||||||||||||||
Balance as at
|
||||||||||||||||||||||||||||||||||||||||
December 31, 2020
|
25,102
|
82,401
|
8,191
|
(1,736
|
)
|
3,823
|
341
|
6,106
|
124,228
|
798
|
125,026
|
Non- controlling
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Attributable to shareholders of the Company
|
Interests
|
Equity
|
||||||||||||||||||||||||||||||||||||||
Share capital
|
Share premium
|
Retained earnings
|
Treasury shares
|
Translation reserve from
foreign operations
|
Hedging Reserve
|
Interests Transaction reserve with
non-controlling Interests
|
Total
|
|||||||||||||||||||||||||||||||||
Convenience translation into US$ (exchange rate as at March 31, 2021: euro 1 = US$ 1.174)
|
||||||||||||||||||||||||||||||||||||||||
For the three month ended March 31, 2021 (unaudited):
|
||||||||||||||||||||||||||||||||||||||||
Balance as at January 1, 2021
|
29,459
|
96,704
|
9,613
|
(2,037
|
)
|
4,487
|
400
|
7,166
|
145,792
|
937
|
146,729
|
|||||||||||||||||||||||||||||
Loss for the period
|
-
|
-
|
(2,428
|
)
|
-
|
-
|
-
|
-
|
(2,428
|
)
|
(702
|
)
|
(3,130
|
)
|
||||||||||||||||||||||||||
Other comprehensive income (loss) for the period
|
-
|
-
|
-
|
-
|
655
|
(1,960
|
)
|
-
|
(1,305
|
)
|
(1,477
|
)
|
(2,782
|
)
|
||||||||||||||||||||||||||
Total comprehensive income (loss) for the period
|
-
|
-
|
(2,428
|
)
|
-
|
655
|
(1,960
|
)
|
-
|
(3,733
|
)
|
(2,179
|
)
|
(5,912
|
)
|
|||||||||||||||||||||||||
Transactions with owners of the Company, recognized directly in equity:
|
||||||||||||||||||||||||||||||||||||||||
Buy of shares in subsidiaries from non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,128
|
)
|
(1,128
|
)
|
1,128
|
-
|
||||||||||||||||||||||||||||
Warrants exercise
|
533
|
3,929
|
-
|
-
|
-
|
-
|
-
|
4,462
|
-
|
4,462
|
||||||||||||||||||||||||||||||
Options exercise
|
26
|
-
|
-
|
-
|
-
|
-
|
-
|
26
|
-
|
26
|
||||||||||||||||||||||||||||||
Share-based payments
|
-
|
8
|
-
|
-
|
-
|
-
|
-
|
8
|
-
|
8
|
||||||||||||||||||||||||||||||
Balance as at
|
||||||||||||||||||||||||||||||||||||||||
March 31, 2021
|
30,018
|
100,641
|
7,185
|
(2,037
|
)
|
5,142
|
(1,560
|
)
|
6,038
|
145,427
|
(114
|
)
|
145,313
|
For the three months ended March 31,
|
For the year ended December 31,
|
For the three months ended March 31,
|
||||||||||||||
2021
|
2020
|
2020
|
2021
|
|||||||||||||
Unaudited
|
Audited
|
Unaudited
|
||||||||||||||
€ in thousands
|
Convenience Translation into US$* in thousands
|
|||||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Loss for the period
|
(2,666
|
)
|
(1,865
|
)
|
(6,168
|
)
|
(3,130
|
)
|
||||||||
Adjustments for:
|
||||||||||||||||
Financing expenses, net
|
2,766
|
413
|
3,634
|
3,247
|
||||||||||||
Profit from settlement of derivatives contract
|
(407
|
)
|
-
|
-
|
(478
|
)
|
||||||||||
Depreciation and amortization
|
3,051
|
726
|
2,975
|
3,581
|
||||||||||||
Share-based payment transactions
|
7
|
14
|
50
|
8
|
||||||||||||
Share of profits of equity accounted investees
|
(617
|
)
|
(1,331
|
)
|
(1,525
|
)
|
(724
|
)
|
||||||||
Payment of interest on loan from an equity accounted investee
|
-
|
582
|
582
|
-
|
||||||||||||
Change in trade receivables and other receivables
|
(1,182
|
)
|
588
|
(3,868
|
)
|
(1,387
|
)
|
|||||||||
Change in other assets
|
30
|
(215
|
)
|
179
|
35
|
|||||||||||
Change in receivables from concessions project
|
221
|
201
|
1,426
|
259
|
||||||||||||
Change in trade payables
|
(382
|
)
|
315
|
190
|
(448
|
)
|
||||||||||
Change in other payables
|
1,596
|
(274
|
)
|
(1,226
|
)
|
1,873
|
||||||||||
Income tax expense (tax benefit)
|
(319
|
)
|
104
|
(125
|
)
|
(374
|
)
|
|||||||||
Income taxes paid
|
-
|
-
|
(119
|
)
|
-
|
|||||||||||
Interest received
|
427
|
441
|
2,075
|
501
|
||||||||||||
Interest paid
|
(1,206
|
)
|
(168
|
)
|
(3,906
|
)
|
(1,415
|
)
|
||||||||
3,985
|
1,396
|
342
|
4,678
|
|||||||||||||
Net cash from (used in) operating activities
|
1,319
|
(469
|
)
|
(5,826
|
)
|
1,548
|
||||||||||
Cash flows from investing activities
|
||||||||||||||||
Acquisition of fixed assets
|
(25,653
|
)
|
(41,414
|
)
|
(128,420
|
)
|
(30,106
|
)
|
||||||||
Acquisition of subsidiary, net of cash acquired
|
-
|
-
|
(7,464
|
)
|
-
|
|||||||||||
Compensation as per agreement with Erez Electricity Ltd.
|
-
|
-
|
1,418
|
-
|
||||||||||||
Repayment of loan from an equity accounted investee
|
-
|
1,923
|
1,978
|
-
|
||||||||||||
Loan to an equity accounted investee
|
(113
|
)
|
-
|
(181
|
)
|
(133
|
)
|
|||||||||
Advances on account of investments
|
-
|
-
|
(1,554
|
)
|
-
|
|||||||||||
Settlement of derivatives
|
(252
|
)
|
-
|
-
|
(296
|
)
|
||||||||||
Proceed from restricted cash, net
|
454
|
22,585
|
23,092
|
533
|
||||||||||||
Proceed from (investment) in short term deposit
|
8,533
|
-
|
(1,323
|
)
|
10,014
|
|||||||||||
Proceeds from marketable securities
|
1,785
|
-
|
1,800
|
2,095
|
||||||||||||
Acquisition of marketable securities
|
-
|
-
|
(1,481
|
)
|
-
|
|||||||||||
Net cash used in investing activities
|
(15,246
|
)
|
(16,906
|
)
|
(112,135
|
)
|
(17,893
|
)
|
||||||||
Cash flows from financing activities
|
||||||||||||||||
Issuance of warrants
|
-
|
320
|
2,544
|
-
|
||||||||||||
Acquisition of shares in subsidiaries from non-controlling interests
|
1,400
|
-
|
-
|
1,643
|
||||||||||||
Proceeds from options
|
22
|
-
|
20
|
26
|
||||||||||||
Cost associated with long term loans
|
(197
|
)
|
-
|
(734
|
)
|
(231
|
)
|
|||||||||
Proceeds from long term loans
|
27,061
|
40,923
|
111,357
|
31,758
|
||||||||||||
Repayment of long-term loans
|
(457
|
)
|
(810
|
)
|
(3,959
|
)
|
(536
|
)
|
||||||||
Repayment of Debentures
|
(21,877
|
)
|
(22,162
|
)
|
(26,923
|
)
|
(25,674
|
)
|
||||||||
Exercise of warrants
|
3,675
|
13,188
|
21,275
|
4,313
|
||||||||||||
Proceeds from issue of convertible debentures, net
|
15,571
|
-
|
-
|
18,274
|
||||||||||||
Proceeds from issuance of Debentures, net
|
25,465
|
-
|
38,057
|
29,885
|
||||||||||||
Net cash from financing activities
|
50,663
|
31,459
|
141,637
|
59,458
|
||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents
|
1,439
|
(828
|
)
|
(1,340
|
)
|
1,688
|
||||||||||
Increase in cash and cash equivalents
|
38,175
|
13,256
|
22,336
|
44,801
|
||||||||||||
Cash and cash equivalents at the beginning of the period
|
66,845
|
44,509
|
44,509
|
78,448
|
||||||||||||
Cash and cash equivalents at the end of the period
|
105,020
|
57,765
|
66,845
|
123,249
|
PV
|
Total
|
|||||||||||||||||||||||||||||||||||||||
reportable
|
Total
|
|||||||||||||||||||||||||||||||||||||||
Italy
|
Spain
|
Israel1
|
Talasol
|
Biogas
|
Dorad
|
Manara
|
segments
|
Reconciliations
|
consolidated
|
|||||||||||||||||||||||||||||||
For the three months ended March 31, 2021
|
||||||||||||||||||||||||||||||||||||||||
€ in thousands
|
||||||||||||||||||||||||||||||||||||||||
Revenues
|
-
|
784
|
832
|
3,089
|
2
|
3,098
|
12,227
|
-
|
20,030
|
(12,830
|
)
|
7,200
|
||||||||||||||||||||||||||||
Operating expenses
|
-
|
(132
|
)
|
(81
|
)
|
(611
|
)
|
(2,393
|
)
|
(9,279
|
)
|
-
|
(12,496
|
)
|
9,279
|
(3,217
|
)
|
|||||||||||||||||||||||
Depreciation and amortization expenses
|
-
|
(237
|
)
|
(574
|
)
|
(1,915
|
)
|
(771
|
)
|
(1,212
|
)
|
-
|
(4,709
|
)
|
1,658
|
(3,051
|
)
|
|||||||||||||||||||||||
Gross profit (loss)
|
-
|
415
|
177
|
563
|
(66
|
)
|
1,736
|
-
|
2,825
|
(1,893
|
)
|
932
|
||||||||||||||||||||||||||||
Project development costs
|
(505
|
)
|
||||||||||||||||||||||||||||||||||||||
General and
|
||||||||||||||||||||||||||||||||||||||||
administrative expenses
|
(1,263
|
)
|
||||||||||||||||||||||||||||||||||||||
Share of profits (loss) of
|
||||||||||||||||||||||||||||||||||||||||
equity accounted investee
|
617
|
|||||||||||||||||||||||||||||||||||||||
Operating loss
|
(219
|
)
|
||||||||||||||||||||||||||||||||||||||
Financing income
|
912
|
|||||||||||||||||||||||||||||||||||||||
Financing income
|
||||||||||||||||||||||||||||||||||||||||
(expenses) in connection
|
||||||||||||||||||||||||||||||||||||||||
with derivatives, net
|
(124
|
)
|
||||||||||||||||||||||||||||||||||||||
Financing expenses, net
|
(3,554
|
)
|
||||||||||||||||||||||||||||||||||||||
Loss before taxes
|
||||||||||||||||||||||||||||||||||||||||
on Income
|
(2,985
|
)
|
||||||||||||||||||||||||||||||||||||||
Segment assets as at
|
||||||||||||||||||||||||||||||||||||||||
March 31, 2021
|
588
|
18,244
|
35,543
|
237,886
|
36,282
|
113,366
|
42,859
|
484,768
|
6,879
|
491,647
|
For the three months ended March 31,
|
For the year ended December 31,
|
For the three months ended March 31,
|
||||||||||||||
2021
|
2020
|
2020
|
2021
|
|||||||||||||
Unaudited
|
||||||||||||||||
€ in thousands
|
Convenience Translation into US$* in thousands
|
|||||||||||||||
Net loss for the period
|
(2,666
|
)
|
(1,865
|
)
|
(6,168
|
)
|
(3,130
|
)
|
||||||||
Financing expenses, net
|
2,766
|
413
|
3,634
|
3,247
|
||||||||||||
Tax benefit (Taxes on income)
|
(319
|
)
|
104
|
(125
|
)
|
(374
|
)
|
|||||||||
Depreciation
|
3,051
|
726
|
2,975
|
3,581
|
||||||||||||
EBITDA
|
2,832
|
(622
|
)
|
316
|
3,324
|
Talasol PV Plant
|
Israel - PV(1)
|
|||||||
For the three months ended
March 31, 2021
|
||||||||
Unaudited
|
||||||||
€ in thousands
|
||||||||
Gross profit
|
563
|
177
|
||||||
General and administrative expenses
|
(138
|
)
|
(47
|
)
|
||||
Operating profit
|
425
|
130
|
||||||
Adjustment
|
845
|
(2)
|
-
|
|||||
Adjusted operating profit
|
1,270
|
-
|
||||||
Depreciation and amortization
|
1,915
|
574
|
||||||
Interest on loans
|
(1,425
|
)
|
(209
|
)
|
||||
Adjusted FFO
|
1,760
|
495
|
|
(1) |
Based on the segment results set forth above, which are adjusted to present the results of the Talmei Yosef PV Plant based on the fixed asset model and not as a financial asset under IFRIC 12.
|
|
(2) |
Results of the Talasol PV Plant for the period until January 27, 2021.
|
Spain - PV
|
Netherlands - Biogas
|
|||||||
For the three months ended
|
||||||||
March 31, 2021
|
||||||||
Unaudited
|
||||||||
€ in thousands
|
||||||||
Gross profit (loss)
|
509
|
(66
|
)
|
|||||
General and administrative expenses
|
(23
|
)
|
(27
|
)
|
||||
Operating profit (loss)
|
486
|
(93
|
)
|
|||||
Depreciation and amortization
|
237
|
771
|
||||||
Interest on loans
|
(69
|
)
|
(109
|
)
|
||||
FFO
|
654
|
569
|
For the four quarter period ended March 31, 2021
|
||||
Unaudited
|
||||
€ in thousands
|
||||
Loss for the period
|
(6,969
|
)
|
||
Financing expenses, net
|
5,987
|
|||
Taxes on income
|
(548
|
)
|
||
Depreciation
|
5,300
|
|||
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
|
3,013
|
|||
Share-based payments
|
43
|
|||
Adjusted EBITDA as defined the Series C Deed of Trust
|
6,826
|
For the four quarter period ended March 31, 2021
|
||||
Unaudited
|
||||
€ in thousands
|
||||
Loss for the period
|
(6,969
|
)
|
||
Financing expenses, net
|
5,987
|
|||
Taxes on income
|
(548
|
)
|
||
Depreciation
|
5,300
|
|||
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
|
3,013
|
|||
Share-based payments
|
43
|
|||
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters3
|
12,366
|
|||
Adjusted EBITDA as defined the Series D Deed of Trust
|
19,192
|